Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acquired Thrombocytopenia”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableStudy completedNCT05876221
What this trial is testing

Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
University of Cologne 223
Not applicableStudy completedNCT04845113
What this trial is testing

Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children

Who this might be right for
Idiopathic Purpura
University Hospital, Montpellier 200
Large-scale testing (Phase 3)Ended earlyNCT00678587
What this trial is testing

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Who this might be right for
Non-alcoholic SteatohepatitisChronic Liver DiseaseHCV+8 more
GlaxoSmithKline 292
Very early researchStudy completedNCT04478227
What this trial is testing

TPO-Mimetic Use in Children for Hematopoietic Failure

Who this might be right for
Bone Marrow Failure DisordersAplastic AnemiaThrombocytopenia+2 more
Anjali Sharathkumar 15
Not applicableUnknownNCT05389007
What this trial is testing

.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Johannes Gutenberg University Mainz 156
Testing effectiveness (Phase 2)Study completedNCT01554514
What this trial is testing

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Washington University School of Medicine 19
Not applicableActive Not RecruitingNCT05046717
What this trial is testing

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Fundación Española de Hematología y Hemoterapía 500
Testing effectiveness (Phase 2)Ended earlyNCT03806556
What this trial is testing

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

Who this might be right for
Pediatric CancerThrombocytopeniaHemostatic Disorder+1 more
Meghan McCormick 11
Testing effectiveness (Phase 2)Study completedNCT00907751
What this trial is testing

Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Assistance Publique - Hôpitaux de Paris 12
Testing effectiveness (Phase 2)Study completedNCT03922308
What this trial is testing

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Shire 28
Not applicableLooking for participantsNCT06727669
What this trial is testing

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic PurpuraHemophilia A, Acquired+13 more
Peking University People's Hospital 3,000
Not applicableUnknownNCT05225493
What this trial is testing

HIV Indicator Diseases in Hospital and Primary Care

Who this might be right for
HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more
Erasmus Medical Center 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT05199909
What this trial is testing

Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

Who this might be right for
Antiphospholipid SyndromeThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableEnrolling By InvitationNCT02422875
What this trial is testing

Comparative Autoantibody and Immunologic Cell Marker Study

Who this might be right for
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Emory University 2,500
Post-approval studies (Phase 4)UnknownNCT05135442
What this trial is testing

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Who this might be right for
Thrombotic Thrombocytopenic Purpura, Acquired
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01151423
What this trial is testing

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 75
Large-scale testing (Phase 3)Study completedNCT04074187
What this trial is testing

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Sanofi 21
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Looking for participantsNCT05983952
What this trial is testing

Anti-CD38 Antibody Treating APS With Thrombocytopenia

Who this might be right for
Antiphospholipid SyndromeThrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 10
Load More Results